John Overdeck’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
AIM
John Overdeck's RDY Position: Q2 2026 in Review
John Overdeck sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 21,800 shares — an estimated $302K sold.
John Overdeck first reported a position in RDY in Q4 2015 and held it in 13 quarters. The position peaked at $10.9M in Q2 2023. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- John Overdeck reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
- John Overdeck sold 21,800 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $302K.
- John Overdeck first reported a position in Dr. Reddy's Laboratories in Q4 2015 and held it in 13 quarters.
- John Overdeck's Dr. Reddy's Laboratories position peaked at $10.9M in Q2 2023.
- 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.